drugset / Trial / NCT04171687
Effect of Tegoprazan or RAPA113 on Pharmacodynamics/Pharmacokinetics of Clopidogrel in Healthy Male Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
This study aims to evaluate the influence of tegoprazan or RAPA113 on the pharmacodynamics/Pharmacokinetics of following co-administration of tegoprazan or RAPA113 and clopidogrel in healthy male volunteers.
Timeline
- Start
- 2019-10-21
- Primary completion
- 2020-02-07
- Completion
- 2020-04-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clopidogrel | Small molecule | 75 mg | Oral |
| Subject | RAPA113 | Unknown | — | Oral |
| Subject | Tegoprazan | Other / unclassified | 50 mg | Oral |
Indications
No indication recorded.